Navigation Links
Peregrine Pharmaceuticals Receives Approval to Conduct a Second Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
Date:1/23/2008

-- Peregrine Has Now Received Regulatory Approval for Three Phase II Cancer

Trials to Study Bavituximab in Combination with Chemotherapy -- -- New Clinical Trial Will Evaluate Anti-Tumor Activity of Bavituximab in

Combination with Carboplatin and Paclitaxel --

TUSTIN, Calif., Jan. 23 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM), a clinical stage biopharmaceutical company developing monoclonal antibodies for the treatment of cancer and hepatitis C virus (HCV) infection, today announced that its Phase II clinical protocol to study bavituximab in combination with chemotherapy in patients with advanced breast cancer has been approved by the Drug Controller General of India (DCGI). The primary objective of the multi-center clinical trial is to assess the overall response rate to the combination of bavituximab with carboplatin and paclitaxel, chemotherapy drugs commonly used in the treatment of breast cancer.

In the trial's two-stage design, up to 15 patients with advanced breast cancer will be enrolled initially. The study will then be expanded up to a total of 46 patients if promising results are observed. Secondary objectives of the study include measuring time to tumor progression, duration of response, overall patient survival and safety parameters. Patients may continue to receive bavituximab alone after completion of chemotherapy as long as the cancer does not progress and side effects are acceptable.

"We are eager to begin this new trial because we saw encouraging signs of activity against advanced breast cancer in our bavituximab pilot combination therapy study, where two patients treated with bavituximab and these same chemotherapy agents achieved objective tumor r
'/>"/>

SOURCE Peregrine Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
2. Peregrine Reports Data Showing Bavituximabs Potential to Shrink Prostate Tumors
3. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
4. Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer
5. Peregrine Pharmaceuticals Doses First Patient in Clinical Trial of Bavituximab in HCV Patients Co-Infected With HIV
6. Peregrine Pharmaceuticals Submits Clinical Protocol for New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer
7. New Data Confirms That a Selective, Fully Human Anti-VEGF Antibody Being Developed by Peregrine is as Effective as Avastin(R) in Preclinical Cancer Models
8. Peregrine Announces Addition of The Johns Hopkins Hospital as Study Site for Bavituximab Trial in HCV Patients Co-Infected With HIV
9. Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer
10. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
11. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... CAESAREA, Israel , May 22, 2013 /PRNewswire/ ... data presented from the DEFLECT-I study demonstrates that Keystone ... lesion volume during TAVR (Transcatheter Aortic Valve Replacement) procedures ... Scientific Advisory Board announces consensus on the importance of ... importance and need for cerebral protection during cardiovascular procedures ...
(Date:5/22/2013)... Inc., a premier global consulting and actuarial firm, today ... (MMI), which measures the healthcare costs for a typical ... employer-sponsored preferred provider organization (PPO) plan. The cost of ... "For the second consecutive year, the ... was the lowest in the history of the study—and ...
(Date:5/22/2013)... 2013 Pomerantz Grossman Hufford Dahlstrom ... behalf of investors of Intuitive Surgical, Inc. ("Intuitive Surgical" ... 46120E602) who purchased Intuitive Surgical common stock between October ... Such investors are advised to contact Robert ... 888-476-6529, ext. 237. The investigation concerns whether ...
Breaking Medicine Technology:New Clinical Data Presented at EuroPCR Demonstrates that TriGuard Reduces Brain Lesion Volume during TAVR 2New Clinical Data Presented at EuroPCR Demonstrates that TriGuard Reduces Brain Lesion Volume during TAVR 3New Clinical Data Presented at EuroPCR Demonstrates that TriGuard Reduces Brain Lesion Volume during TAVR 4Annual Healthcare Cost for a Typical American Family is $22,030 According to 2013 Milliman Medical Index 2SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Intuitive Surgical, Inc. - ISRG 2
(Date:5/22/2013)... CA (PRWEB) May 22, 2013 ... hosted by Patricia O’Laughlin Psychotherapy in the Silver ... people of all ages as progression to existing ... of all ages into parenting therapy has always ... emphasizes. Patricia O’Laughlin Psychotherapy now specializes in all ...
(Date:5/22/2013)... ID (PRWEB) May 22, 2013 Bodybuilding.com ... This Memorial Day (May 27, 2013) Bodybuilding.com will be donating ... of the amount. , “We are extremely grateful for ... the Armed Forces,” said Ryan DeLuca, CEO and founder of ... heroes who have sacrificed so much. Hire Heroes USA is ...
(Date:5/22/2013)... According to a May 14, 2013 US News ... Breast Cancer Surgery,” modern medical technology has given women with ... in a whole new light. Since the new approach known ... breast cancer and mastectomies with greater hope for a ... of plastic surgery to oncology, women had little choice but ...
(Date:5/22/2013)... UT (PRWEB) May 22, 2013 Today, ... Alabama Health Insurance Exchange . Zane Benefits, which ... health benefits, is the leader in defined contribution ... According to Zane Benefits’ website, beginning in 2014 as ... coverage for individuals and small businesses will become available ...
(Date:5/22/2013)... from the University of Miami Miller School of Medicine ... up to hold the second annual "Why We Can,t ... The theme of this year,s conference will be ... these disparities. , Despite steady improvement in the overall ... continue to be more vulnerable to lapses in care ...
Breaking Medicine News(10 mins):Health News:Patricia O’Laughlin Psychotherapy of Los Angeles Now Seeing Adults, Teens and Young Children 2Health News:In the Spirit of Memorial Day, Bodybuilding.com is Donating a Portion of Their Sales to Hire Heroes 2Health News:Breast Augmentation – New Option for Breast Cancer Surgeries 2Health News:Zane Benefits Publishes New Information on Alabama Health Insurance Exchange 2Health News:Zane Benefits Publishes New Information on Alabama Health Insurance Exchange 3Health News:Why We Can't Wait: Conference to Eliminate Health Disparities in Genomic Medicine 2
... AIRS, a ... multiple, one-hour online classes for recruiters on the go. , ... Lebanon, NH (PRWEB) October 20, 2009 -- AIRS, a market ... Series , offering multiple, one-hour online classes for recruiters on the go. , , , ...
... ... all the loads in the new tower, including HVAC. Having a reliable standby power ... east central Florida is hit frequently by hurricanes and thunderstorms that cause disruptions in grid ... Daytona Beach, Florida ...
... American adults with chronic illnesses like diabetes or high ... increased risk of costly, disabling and even lethal complications ... [Tuesday] in Health Affairs , analyzed data from ... Disease Control and Prevention (CDC). The researchers, based at ...
... ... of Rules Technology without Spending a Dime , ... Redwood City, CA (PRWEB) October 19, 2009 -- Corticon ... today another breakthrough in the Business Rules industry with the immediate availability of Corticon ...
... Oct. 19 Today, the U.S. Department of Justice issued ... laws authorizing the use of marijuana for medical purposes. A ... States Attorneys outlined the new position of the department. , ... of these [controlled substances] priorities should not focus ...
... of Sterling Heights, Mich., pleaded guilty today in U.S. ... to defraud the Medicare program, announced Assistant Attorney General ... Terrence Berg of the Eastern District of Michigan and ... Health & Human Services (HHS). , In ...
Cached Medicine News:Health News:AIRS High Impact Series Offers Quick Solutions for Busy Recruiters 2Health News:AIRS High Impact Series Offers Quick Solutions for Busy Recruiters 3Health News:Florida's Halifax Health Relies on Standby Power System from MTU Onsite Energy for New 10-Story Emergency Facility 2Health News:Florida's Halifax Health Relies on Standby Power System from MTU Onsite Energy for New 10-Story Emergency Facility 3Health News:Illness often undiscovered and undertreated among the uninsured: Harvard study 2Health News:Corticon Launches RuleWorld Community and Free Business Rules Software 2Health News:Corticon Launches RuleWorld Community and Free Business Rules Software 3Health News:Corticon Launches RuleWorld Community and Free Business Rules Software 4Health News:Detroit-Area Physical Therapist Pleads Guilty in Medicare Fraud Scheme 2
Heavy Duty Locking Pliers...
The double action wire cutter has both side and end cutting capabilities....
... a combination Spectral Optical Coherence Tomography (OCT) ... provides suberb, high-quality images of the vitreo-retina, ... of spectral technology, OTI's sytem can reach ... per second and provide images with a ...
... same cryoconsole and platform technology as Freezor ... veins. Arctic Circler is an ablation tool ... that rely on medication., ,With its ... the ability to create curvilinear lesions rapidly ...
Medicine Products: